Trial Profile

Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 09 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etonogestrel (Primary) ; Medroxyprogesterone
Indications Pregnancy
Focus Pharmacodynamics

Most Recent Events

22 May 2010 Results (effects on haemostatic system) reported at 11th Congress of the European Society of Contraception.
01 Dec 2009 Results published in Contraception.
09 Oct 2009 Pharmacodynamic results, with respect to metabolic parameters, presented at the 19th FIGO World Congress of Gynecology and Obstetrics.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com